![]() | This article reads like a press release or a news article and may be largely based on routine coverage .(December 2020) |
![]() | |
Company type | Public |
---|---|
Industry | Medical Devices |
Founded | 1958 |
Headquarters | San Ramon, California, U.S. |
Area served | Worldwide |
Key people | Albert G. White III (President & CEO) |
Products | Medical Devices |
507,600,000 United States dollar (2022) ![]() | |
385,800,000 United States dollar (2022) ![]() | |
Number of employees | approx. 15,000 (October 2023) |
Website | coopercos |
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. [1] The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market. [2]
CooperCompanies was founded in 1958 as Martin H. Smith Co. and in 1961, incorporated as Cooper Tinsley Laboratories Inc. The company changed its name to Cooper Laboratories Inc. in 1967, [3] and entered the contact lens business when it acquired British lens maker GlobalVision in 1972. [4]
In 1980, Cooper Laboratories reorganized into three business groups: CooperVision, CooperCare and CooperBiomedical, with Cooper Medical Devices Corp. added as a fourth group one year later.[ citation needed ]
The company was renamed The Cooper Companies in 1987. Three years later, it was further restructured into three business units: CooperVision, CooperSurgical and CooperVision Pharmaceuticals (dissolved in 2003).
Currently, the firm operates as two business units: CooperVision and CooperSurgical. [5] CooperVision serves contact lens wearers and eye care practitioners. [6] Products include a range of daily, two-week and monthly disposable contact lenses, and other spherical, toric and multifocal lenses for astigmatism, nearsightedness and farsightedness, and presbyopia. [7]
CooperSurgical is the medical device and fertility and genomics unit of the companies. It became a business unit in 1990 and its focus includes women's health and fertility. [8] [9]
Ocular Sciences Inc. was acquired by CooperVision in 2005. [10]
CooperSurgical acquired AEGEA Medical, a medical manufacturing company in February 2021. [11] A month later, in March, the company acquired Safe Obstetric Systems [12] [9] , and in December 2021, CooperSurgical acquired Generate Life Sciences for $1.6 billion. [13]
In March 2022, CooperSurgical acquired Cook Medical's reproductive health business for $875 million. [14] During that same year the company acquired EnsEyers, a supplier of orthokeratology and scleral contact lenses. [15]